Search
for

    Sort by

    Research 811–840 of 1000+

    1. Contrast-Enhanced Ultrasound (CEUS) Evaluation of Canine Prostatic Hyperplasia before and after Osaterone Acetate Therapy: Preliminary Results Animals · 2024 · 4 citations
    2. Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments Clinical Epidemiology · 2022 · 4 citations
    3. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States 2016 · 4 citations
    4. Expression and Cellular Localization of Keratinocyte Growth Factor and Its Receptor in Human Hyperplastic Prostate Tissue<sup>1</sup> The Journal of Clinical Endocrinology & Metabolism · 1998 · 4 citations
    5. Phytotherapy in Benign Prostatic Hyperplasia Elsevier eBooks · 2018 · 3 citations
    6. Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays Phytotherapy Research · 2016 · 3 citations
    7. Regarding prostate-specific antigen: let's not shoot the messenger QJM · 2011 · 3 citations
    8. Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases The World Journal of Men s Health · 2024 · 2 citations
    9. Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink European Urology · 2017 · 2 citations
    10. Effect of finasteride on prostate-specific antigen Lancet Oncology · 2006 · 2 citations
    11. Zhuangyao Jianshen pill ameliorates testosterone-induced benign postatic hyperplasia in rats. PubMed · 2024 · 1 citations
    12. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Curēus · 2023 · 1 citations
    13. Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study Scientific Reports · 2023 · 1 citations
    14. 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study British Journal of Clinical Pharmacology · 2022 · 1 citations
    15. Inhibition of Proliferation of LNCaP Prostate Cells by Corni Fructus Extract Is Associated with a Decrease in the Expression of Benign Prostatic Hyperplasia-Causing Factors Journal of Korean Medicine for Obesity Research · 2021 · 1 citations
    16. A histological study of the effect of panax ginseng versus finasteride on induced benign prostatic hyperplasia in rats with potentiality of spontaneous recovery The Egyptian Journal of Histology · 2020 · 1 citations
    17. Effect of a Benign Prostatic Hyperplasia (BPH) Xenobiotic - Croton membranaceus Müll.Arg. Root Extract on CYP1A2, CYP3A4, CYP2D6, and GSTM1 Drug Metabolizing Enzymes in Rat Model 2020 · 1 citations
    18. Asociación entre disfunción eréctil y funcionalidad del subsistema conyugal en pacientes con hiperplasia prostática benigna REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora · 2020 · 1 citations
    19. Acción de Finasteride sobre el volumen prostático en caninos con hiperplasia prostática benigna El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · 2002 · 1 citations
    20. Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers vs 5-Alpha Reductase Inhibitors Urology · 2026
    21. Modulation of AR-FGF-2-TGF beta Axis by Cosmos caudatus Suppresses Prostatic Epithelial Proliferation in a BPH Rat Model: A Comparative Study with Finasteride Journal of Multidisciplinary Applied Natural Science · 2026
    22. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    23. Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2026
    24. Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2026
    25. Adverse effects of finasteride in men treated for benign prostatic hyperplasia and androgenetic alopecia - a literature review Journal of Education Health and Sport · 2025
    26. Efficacy, safety, and adverse effects of finasteride and dutasteride in treating benign prostatic hyperplasia: A retrospective cohort study Zanco Journal of Medical Sciences · 2024
    27. Re: The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA): A population‐based case–control study Australasian Journal of Dermatology · 2024
    28. Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia LUTS Lower Urinary Tract Symptoms · 2024
    29. The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia and androgenetic alopecia: A population‐based case–control study Australasian Journal of Dermatology · 2024
    30. The Association of Male Pattern Baldness in Men with Benign Prostatic Hyperplasia Jordan Medical Journal · 2023